Literature DB >> 33401408

Trends in Antibiotic Prescribing in Out-of-Hours Primary Care in England from January 2016 to June 2020 to Understand Behaviours during the First Wave of COVID-19.

Nina J Zhu1, Monsey McLeod1,2,3, Cliodna A M McNulty4, Donna M Lecky4, Alison H Holmes1,5,6,7, Raheelah Ahmad1,8.   

Abstract

We describe the trend of antibiotic prescribing in out-of-hours (OOH) general practices (GP) before and during England's first wave of the COVID-19 pandemic. We analysed practice-level prescribing records between January 2016 to June 2020 to report the trends for the total prescribing volume, prescribing of broad-spectrum antibiotics and key agents included in the national Quality Premium. We performed a time-series analysis to detect measurable changes in the prescribing volume associated with COVID-19. Before COVID-19, the total prescribing volume and the percentage of broad-spectrum antibiotics continued to decrease in-hours (IH). The prescribing of broad-spectrum antibiotics was higher in OOH (OOH: 10.1%, IH: 8.7%), but a consistent decrease in the trimethoprim-to-nitrofurantoin ratio was observed OOH. The OOH antibiotic prescribing volume diverged from the historical trend in March 2020 and started to decrease by 5088 items per month. Broad-spectrum antibiotic prescribing started to increase in OOH and IH. In OOH, co-amoxiclav and doxycycline peaked in March to May in 2020, which was out of sync with seasonality peaks (Winter) in previous years. While this increase might be explained by the implementation of the national guideline to use co-amoxiclav and doxycycline to manage pneumonia in the community during COVID-19, further investigation is required to see whether the observed reduction in OOH antibiotic prescribing persists and how this reduction might influence antimicrobial resistance and patient outcomes.

Entities:  

Keywords:  COVID-19; antibiotics; antimicrobial stewardship; out-of-hours

Year:  2021        PMID: 33401408      PMCID: PMC7824631          DOI: 10.3390/antibiotics10010032

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  14 in total

1.  Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR).

Authors:  Diane Ashiru-Oredope; Susan Hopkins
Journal:  J Antimicrob Chemother       Date:  2013-09-11       Impact factor: 5.790

2.  Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotics in the community: an interrupted time series analysis.

Authors:  Sabine Bou-Antoun; Ceire Costelloe; Kate Honeyford; Mahsa Mazidi; Benedict W J Hayhoe; Alison Holmes; Alan P Johnson; Paul Aylin
Journal:  J Antimicrob Chemother       Date:  2018-10-01       Impact factor: 5.790

3.  Tackling antimicrobial resistance 2019-2024 - The UK's five-year national action plan.

Authors:  M Courtenay; E Castro-Sanchez; M Fitzpatrick; R Gallagher; R Lim; G Morris
Journal:  J Hosp Infect       Date:  2019-03-01       Impact factor: 3.926

4.  The Impact of a National Antimicrobial Stewardship Program on Antibiotic Prescribing in Primary Care: An Interrupted Time Series Analysis.

Authors:  Violeta Balinskaite; Alan P Johnson; Alison Holmes; Paul Aylin
Journal:  Clin Infect Dis       Date:  2019-07-02       Impact factor: 9.079

5.  Doctors to get real time data to support antibiotic prescribing and reduce resistance.

Authors:  Susan Mayor
Journal:  BMJ       Date:  2019-01-25

6.  Potential for reducing inappropriate antibiotic prescribing in English primary care.

Authors:  Timo Smieszek; Koen B Pouwels; F Christiaan K Dolk; David R M Smith; Susan Hopkins; Mike Sharland; Alastair D Hay; Michael V Moore; Julie V Robotham
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

7.  Increase in antibiotic prescriptions in out-of-hours primary care in contrast to in-hours primary care prescriptions: service evaluation in a population of 600 000 patients.

Authors:  G N Hayward; R F R Fisher; G T Spence; D S Lasserson
Journal:  J Antimicrob Chemother       Date:  2016-06-10       Impact factor: 5.790

8.  Interrupted time series regression for the evaluation of public health interventions: a tutorial.

Authors:  James Lopez Bernal; Steven Cummins; Antonio Gasparrini
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

9.  Trends and patterns in antibiotic prescribing among out-of-hours primary care providers in England, 2010-14.

Authors:  Michael Edelstein; Adeola Agbebiyi; Diane Ashiru-Oredope; Susan Hopkins
Journal:  J Antimicrob Chemother       Date:  2017-12-01       Impact factor: 5.790

10.  COVID-19 and the potential long-term impact on antimicrobial resistance.

Authors:  Timothy M Rawson; Luke S P Moore; Enrique Castro-Sanchez; Esmita Charani; Frances Davies; Giovanni Satta; Matthew J Ellington; Alison H Holmes
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

View more
  8 in total

1.  Catch-22: War, Refugees, COVID-19, and the Scourge of Antimicrobial Resistance.

Authors:  Marwan Osman; Kevin J Cummings; Khaled El Omari; Issmat I Kassem
Journal:  Front Med (Lausanne)       Date:  2022-06-24

2.  Carbapenem use correlates with percentage of patients with COVID-19 in intensive care units.

Authors:  Salma AlBahrani; Feras Almogbel; Wafa Alanazi; Saleh Hamdi Almutairi; Mohammed Alanazi; Sameh Maximos; Faten Azaiez; Assim Osman; Sharifah Almuthen; Arulanantham Zechariah Jebakumar; Jaffar A Al-Tawfiq
Journal:  Infection       Date:  2022-06-18       Impact factor: 7.455

3.  Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic.

Authors:  Santiago Grau; Daniel Echeverria-Esnal; Silvia Gómez-Zorrilla; Maria Eugenia Navarrete-Rouco; Joan Ramon Masclans; Merce Espona; Maria Pilar Gracia-Arnillas; Xavier Duran; Merce Comas; Juan Pablo Horcajada; Olivia Ferrández
Journal:  Antibiotics (Basel)       Date:  2021-01-29

4.  Non-Visit-Based and Non-Infection-Related Antibiotic Use in the US: A Cohort Study of Privately Insured Patients During 2016-2018.

Authors:  Michael A Fischer; Mufaddal Mahesri; Joyce Lii; Jeffrey A Linder
Journal:  Open Forum Infect Dis       Date:  2021-08-01       Impact factor: 3.835

Review 5.  Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.

Authors:  Doris Rusic; Marino Vilovic; Josipa Bukic; Dario Leskur; Ana Seselja Perisin; Marko Kumric; Dinko Martinovic; Ana Petric; Darko Modun; Josko Bozic
Journal:  Life (Basel)       Date:  2021-03-10

6.  Antibiotic Prescribing Trends in Belgian Out-of-Hours Primary Care during the COVID-19 Pandemic: Observational Study Using Routinely Collected Health Data.

Authors:  Annelies Colliers; Jeroen De Man; Niels Adriaenssens; Veronique Verhoeven; Sibyl Anthierens; Hans De Loof; Hilde Philips; Samuel Coenen; Stefan Morreel
Journal:  Antibiotics (Basel)       Date:  2021-12-04

7.  Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England.

Authors:  Aleksandra J Borek; Katherine Maitland; Monsey McLeod; Anne Campbell; Benedict Hayhoe; Christopher C Butler; Liz Morrell; Laurence S J Roope; Alison Holmes; Ann Sarah Walker; Sarah Tonkin-Crine
Journal:  Antibiotics (Basel)       Date:  2021-12-14

8.  Antibiotic Prescribing in Dutch Daytime and Out-of-Hours General Practice during the COVID-19 Pandemic: A Retrospective Database Study.

Authors:  Karin Hek; Lotte Ramerman; Yvette M Weesie; Anke C Lambooij; Maarten Lambert; Marianne J Heins; Janneke M T Hendriksen; Robert A Verheij; Jochen W L Cals; Liset van Dijk
Journal:  Antibiotics (Basel)       Date:  2022-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.